Product / Service Summary
Tacalyx researches and develops therapeutics directed against TACAs (tumour-associated carbohydrate antigens). These strongly tumor-specific structures are synthesized by cancer cells and contribute significantly to its virulence and metastasis.
The recent synthesis of these complex structures - TACAs (tumor-associated carbohydrate antigens) - allows the production of specific antibodies that can be used for the treatment of currently unsatisfactorily treatable cancers.
Tacalyx Team Members
Recent news about Tacalyx